The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Embold Health today announced the launch of Embold Edge, the first national quality-driven health plan designed to help employers and health plans reduce healthcare costs by addressing one of the most ...

(RTTNews) - Shares of Praxis Precision Medicines, Inc. (PRAX) are up over 20% at $234.00 in premarket trading, after the Data Monitoring Committee recommended early stopping of the EMBOLD study of ...

The transaction is expected to close within the next 14 days Embold will continue to operate as an independent entity Quantum Health was founded in 1999 Quantum Health, which is backed by Warburg ...

DUBLIN, Ohio & NASHVILLE, Tenn.--(BUSINESS WIRE)--Quantum Health (“Quantum”), the creator of healthcare navigation, has signed a definitive agreement to acquire Embold Health (“Embold”), a leading ...

Embold Health, the industry leader in objective physician quality measurement, announced the appointment of two new key roles to continue to meet the needs of current clients and fuel growth and ...

Expanded clinical insights, responsible AI and deeper ecosystem integrations define a milestone year NASHVILLE, Tenn.--(BUSINESS WIRE)--Embold Health is completing a transformative year defined by ...

Influencer marketing management company Embold has launched a new offering that aims to streamline the process of launching influencer campaigns. CampaignPlus is designed to make influencer marketing ...

Embold Edge Enables Employers and Health Plans to Launch an Alternative, Quality-Driven Health Plan Without Network or Carrier Disruption For years, employers and health plans have relied on price ...

Praxis Precision Medicines reported that its EMBOLD trial of relutrigine in SCN2A and SCN8A developmental and epileptic encephalopathies was stopped early for efficacy, while also confirming FDA ...